ReviewCurrent psychiatry reports2026
From Data to Early Diagnosis: Artificial Intelligence as a Tool to Support Screening and Detection of Autism Spectrum Disorder in Childhood.
Review in Current psychiatry reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewAutism spectrum disorder (ASD) is a neurodevelopmental condition with significant implications for childhood development and public health. Early detection is critical to enable timely intervention, yet access to specialised assessment remains limited in many settings. In this context, artificial intelligence (AI) has gained increasing attention as a potential tool to support early ASD screening. This review summarises recent evidence on the use of AI for the screening and early detection in childhood. RECENT
findingsRecent studies generally report favorable results for AI-based approaches, particularly in pediatric populations. Multimodal models that integrate data from questionnaires, video and audio sources tend to outperform single modality approaches, with reported improvements in accuracy and sensitivity. However, most studies remain experimental, with small sample sizes and limited validation in real world clinical environments. AI shows promise as a supportive tool for early screening, but current evidence supports its use as a complement to, rather than replacement for, clinical assessment. Further validation in routine practice is needed before widespread implementation.
Indexed as
Identifiers
42536257What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.